Gilead Sciences (1GILD) Ownership - Who Owns Gilead Sciences?
Gilead Sciences (1GILD) Ownership Overview
- 0.08% Insiders
- 28.35% Mutual Funds
- 2.81% Other Institutional Investors
- 29.19% ETFs
- 39.57% Public Companies and Individual Investors
The ownership structure of Gilead Sciences (IT:1GILD) stock is a mix of institutional, retail, and individual investors. Approximately 60.35% of the company’s stock is owned by Institutional Investors, 0.08% is owned by Insiders, and 39.57% is owned by Public Companies and Individual Investors.
The ownership structure of Gilead Sciences (IT:1GILD) stock is a mix of institutional, retail, and individual investors. Approximately 60.35% of the company’s stock is owned by Institutional Investors, 0.08% is owned by Insiders, and 39.57% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 30, 2025 | Jeffrey Bluestone | $625,400 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Howard Hughes Medical Institute | €32,894 | |
| Dec 31, 2025 | Goalvest Advisory Llc | €46,272 | |
| Dec 31, 2025 | Antipodes Partners Ltd | €68,366 | |
| Dec 31, 2025 | Atwater Malick Llc | €255,053 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 112,246,100 | Institution | 9.05% | 19,417,789,577 |
| Vanguard Index Funds | 84,857,316 | Institution | 6.84% | 14,679,721,667 |
| Ishares | 79,359,512 | Institution | 6.40% | 13,728,640,059 |
| Spdr | 51,210,420 | Institution | 4.13% | 8,859,044,187 |
| Invesco | 48,478,695 | Institution | 3.91% | 8,386,474,884 |
| John A. Gunn | 23,677,567 | Institution | 1.91% | 4,096,053,348 |
| Fidelity Concord Street Trust | 22,430,388 | Institution | 1.81% | 3,880,300,111 |
| Dodge & Cox Funds | 18,312,992 | Institution | 1.48% | 3,168,019,425 |
| Fidelity Contrafund | 15,960,649 | Institution | 1.29% | 2,761,080,552 |
| Income Fund Of America | 15,498,550 | Institution | 1.25% | 2,681,140,660 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 84,857,316 | Institution | 6.84% | 14,679,721,667 |
| Fidelity Concord Street Trust | 22,430,388 | Institution | 1.81% | 3,880,300,111 |
| Dodge & Cox Funds | 18,312,992 | Institution | 1.48% | 3,168,019,425 |
| Fidelity Contrafund | 15,960,649 | Institution | 1.29% | 2,761,080,552 |
| Income Fund Of America | 15,498,550 | Institution | 1.25% | 2,681,140,660 |
| Washington Mutual Investors Fund | 10,310,727 | Institution | 0.83% | 1,783,683,596 |
| American Balanced Fund | 9,637,660 | Institution | 0.78% | 1,667,247,716 |
| Fidelity Securities Fund | 8,091,692 | Institution | 0.65% | 1,399,806,074 |
| Capital Income Builder | 8,051,806 | Institution | 0.65% | 1,392,906,075 |
| Vanguard Institutional Index Funds | 7,334,453 | Institution | 0.59% | 1,268,809,028 |
FAQ
Who Owns Gilead Sciences (IT:1GILD)?
According to the latest TipRanks data, approximately 60.35% of the company's stock is held by institutional investors, 0.08% is held by insiders, and 39.57% is held by public companies and individual investors.
What percentage of Gilead Sciences (IT:1GILD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 60.35% of Gilead Sciences (IT:1GILD) stock is held by institutional investors: 28.35% by mutual funds, 29.19% by ETFs and 2.81% by other institutional investors.
What percentage of Gilead Sciences (IT:1GILD) stock is held by retail investors?
According to the latest TipRanks data, approximately 39.57% of Gilead Sciences (IT:1GILD) stock is held by public companies and individual investors.
Who owns the most shares of Gilead Sciences (IT:1GILD)?
Vanguard owns the most shares of Gilead Sciences (IT:1GILD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.